Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

University of Connecticut

Status: Terminated

Conditions: Aggression; Psychosis

Treatments: Drug: risperidone

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00203775

IRB Project Number 01-250

RIS-USA-T255

RIS-USA-269

Details and patient eligibility

About

This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:age 18 or over, psychotic disorder diagnosed on SCID, inmate at correctional facility for at least 2 weeks -

Exclusion Criteria: active withdrawal from substances of abuse, non-psychotic individuals, pregnant women, people unable to give informed consent, patients on mood stabilizers

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind